Full metadata record

DC Field Value Language
dc.contributor.authorKim, Ji-Hoon-
dc.contributor.authorKang, Jong-Seol-
dc.contributor.authorYoo, Kyusang-
dc.contributor.authorJeong, Jinguk-
dc.contributor.authorPark, Inkuk-
dc.contributor.authorPark, Jong Ho-
dc.contributor.authorRhee, Joonwoo-
dc.contributor.authorJeon, Shin-
dc.contributor.authorJo, Young-Woo-
dc.contributor.authorHann, Sang-Hyeon-
dc.contributor.authorSeo, Minji-
dc.contributor.authorMoon, Seungtae-
dc.contributor.authorUm, Soo-Jong-
dc.contributor.authorSeong, Rho Hyun-
dc.contributor.authorKong, Young-Yun-
dc.date.accessioned2024-01-19T12:02:23Z-
dc.date.available2024-01-19T12:02:23Z-
dc.date.created2022-06-09-
dc.date.issued2022-05-
dc.identifier.issn2324-7703-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/115202-
dc.description.abstractThe survival of motor neuron (SMN) protein is a major component of the pre-mRNA splicing machinery and is required for RNA metabolism. Although SMN has been considered a fundamental gene for the central nervous system, due to its relationship with neuromuscular diseases, such as spinal muscular atrophy, recent studies have also revealed the requirement of SMN in non-neuronal cells in the peripheral regions. Here, we report that the fibro-adipogenic progenitor subpopulation expressing Dpp4 (Dpp4* FAPs) is required for the neuromuscular system. Furthermore, we also reveal that BRCA1-associated protein-1 (Bap1) is crucial for the stabilization of SMN in FAPs by preventing its ubiquitination-dependent degradation. Inactivation of Bap1 in FAPs decreased SMN levels and accompanied degeneration of the neuromuscular junction, leading to loss of motor neurons and muscle atrophy. Overexpression of the ubiquitination-resistant SMN variant, SMNK186R, in Bap1-null FAPs completely prevented neuromuscular degeneration. In addition, transplantation of Dpp4* FAPs, but not Dpp4??? FAPs, completely rescued neuromuscular defects. Our data reveal the crucial role of Bap1-mediated SMN stabilization in Dpp4* FAPs for the neuromuscular system and provide the possibility of cell-based therapeutics to treat neuromuscular diseases.-
dc.languageEnglish-
dc.publisherAMER SOC CLINICAL INVESTIGATION INC-
dc.titleBap1/SMN axis in Dpp4+ skeletal muscle mesenchymal cells regulates the neuromuscular system-
dc.typeArticle-
dc.identifier.doi10.1172/jci.insight.158380-
dc.description.journalClass1-
dc.identifier.bibliographicCitationJCI INSIGHT, v.7, no.10-
dc.citation.titleJCI INSIGHT-
dc.citation.volume7-
dc.citation.number10-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000802196700001-
dc.relation.journalWebOfScienceCategoryMedicine, Research & Experimental-
dc.relation.journalResearchAreaResearch & Experimental Medicine-
dc.type.docTypeArticle-
dc.subject.keywordPlusSPINAL MUSCULAR-ATROPHY-
dc.subject.keywordPlusMOTOR-NEURON PROTEIN-
dc.subject.keywordPlusSKELETAL-MUSCLE-
dc.subject.keywordPlusSMN PROTEIN-
dc.subject.keywordPlusNEUROMUSCULAR-JUNCTION-
dc.subject.keywordPlusMOUSE MODELS-
dc.subject.keywordPlusFIBRO/ADIPOGENIC PROGENITORS-
dc.subject.keywordPlusSELECTIVE VULNERABILITY-
dc.subject.keywordPlusMESENCHYMAL PROGENITOR-
dc.subject.keywordPlusCELLS CONTRIBUTE-
Appears in Collections:
KIST Article > 2022
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE